Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients.
暂无分享,去创建一个
L. Gabrielli | I. Godoy | J. Jalil | S. Córdova | M. Ocaranza | U. Novoa | J. Bulnes | Ch. Cantin | Paul MacNab
[1] J. Jalil,et al. Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling. , 2018, Clinical science.
[2] J. Jalil,et al. Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels. , 2016, International journal of cardiology.
[3] L. Calò,et al. The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling , 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[4] X. Jeunemaître,et al. Angiotensin II Activates the RhoA Exchange Factor Arhgef1 in Humans , 2015, Hypertension.
[5] J. Stull,et al. Myosin Phosphatase Target Subunit 1 (MYPT1) Regulates the Contraction and Relaxation of Vascular Smooth Muscle and Maintains Blood Pressure* , 2014, The Journal of Biological Chemistry.
[6] L. Gabrielli,et al. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy. , 2014, American journal of hypertension.
[7] A. Nakashima,et al. Rho-Associated Kinase Activity Is a Predictor of Cardiovascular Outcomes , 2014, Hypertension.
[8] K. Chayama,et al. Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho‐Associated Kinase Activity in Patients With Hypertension , 2012, Clinical pharmacology and therapeutics.
[9] M. Chiong,et al. Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure. , 2011, American heart journal.
[10] K. Chayama,et al. Calcium channel blocker and Rho-associated kinase activity in patients with hypertension , 2011, Journal of hypertension.
[11] P. Ganz,et al. Statins inhibit Rho kinase activity in patients with atherosclerosis. , 2009, Atherosclerosis.
[12] P. Ganz,et al. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. , 2009, The American journal of cardiology.
[13] Hiroaki Shimokawa,et al. Development of Rho-kinase inhibitors for cardiovascular medicine. , 2007, Trends in pharmacological sciences.
[14] A. Takeshita,et al. Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine , 2005 .
[15] Mario Chiong,et al. La vía de señalización Rho/Rho-cinasa en la enfermedad y el remodelado cardiovascular , 2005 .
[16] M. Chiong,et al. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling]. , 2005, Revista espanola de cardiologia.
[17] K. Chayama,et al. Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil. , 2011, Atherosclerosis.